Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 18.51 GBX -1.28%
Market Cap: 76.3m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Wall Street
Price Targets

CREO Price Targets Summary
Creo Medical Group PLC

Wall Street analysts forecast CREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CREO is 76.5 GBX with a low forecast of 70.7 GBX and a high forecast of 84 GBX.

Lowest
Price Target
70.7 GBX
282% Upside
Average
Price Target
76.5 GBX
313% Upside
Highest
Price Target
84 GBX
354% Upside
Creo Medical Group PLC Competitors:
Price Targets
GN
GN Store Nord A/S
63% Upside
4543
Terumo Corp
16% Upside
1302
LifeTech Scientific Corp
59% Upside
9996
Peijia Medical Ltd
30% Upside
6951
JEOL Ltd
62% Upside
SGHT
Sight Sciences Inc
62% Upside
ABT
Abbott Laboratories
12% Upside
BSX
Boston Scientific Corp
9% Upside

Revenue
Forecast

Revenue Estimate
Creo Medical Group PLC

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 3 years is -3%.

N/A
Past Growth
-3%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CREO's stock price target?
Price Target
76.5 GBX

According to Wall Street analysts, the average 1-year price target for CREO is 76.5 GBX with a low forecast of 70.7 GBX and a high forecast of 84 GBX.

What is Creo Medical Group PLC's Revenue forecast?
Projected CAGR
-3%

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 3 years is -3%.

Back to Top